BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,573,686 | +44.8% | 97,599 | -5.6% | 0.01% | +60.0% |
| Q2 2023 | $1,777,551 | +72.8% | 103,346 | +66.5% | 0.01% | +66.7% |
| Q1 2023 | $1,028,938 | -1.5% | 62,059 | -54.7% | 0.00% | 0.0% |
| Q4 2022 | $1,044,870 | -25.6% | 137,122 | -2.9% | 0.00% | -25.0% |
| Q3 2022 | $1,404,000 | -6.5% | 141,224 | -14.6% | 0.00% | 0.0% |
| Q2 2022 | $1,502,000 | -25.3% | 165,423 | -16.5% | 0.00% | 0.0% |
| Q1 2022 | $2,011,000 | -16.4% | 198,089 | +37.4% | 0.00% | -20.0% |
| Q4 2021 | $2,405,000 | -63.1% | 144,189 | +3.6% | 0.01% | -64.3% |
| Q3 2021 | $6,524,000 | -23.1% | 139,189 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $8,485,000 | +8.7% | 139,189 | +9.9% | 0.02% | +5.9% |
| Q1 2021 | $7,804,000 | +5.6% | 126,689 | +21.9% | 0.02% | 0.0% |
| Q4 2020 | $7,388,000 | +68.6% | 103,900 | -11.0% | 0.02% | +54.5% |
| Q3 2020 | $4,382,000 | +15.0% | 116,800 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $3,809,000 | +13.5% | 116,800 | +1.0% | 0.01% | 0.0% |
| Q1 2020 | $3,355,000 | +179.1% | 115,700 | +237.3% | 0.01% | +266.7% |
| Q4 2019 | $1,202,000 | +63.3% | 34,300 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $736,000 | – | 34,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |